Selective expression of TRPC1-based SOCs and Orai1-based CRAC channels in distinct VSMC phenotypes may provide useful strategies for developing therapeutic strategies to treat distinct progression phases of cardiovascular diseases such as hypertension and atherosclerosis. Here, TRPC1 is linked to cardiovascular disorder.